Year in review: 2024-2025
Pediatric cancer patient AJ
Specialties

Cancer Care

“Landing on the doorstep of UC Davis was probably one of the biggest blessings throughout all of this.”

– Christina Moreno, whose son AJ received treatment after being diagnosed with Stage IV Wilms tumor, a rare kidney cancer.

  • Making cancer less stressful for patients, families

    In partnership with Keaton’s Child Cancer Alliance, our pediatric patients and their families have access to resources and family navigators to help ease stress during cancer treatment. Keaton’s provides direct financial support to families to assist with basic needs and other essential expenses, delivers culturally familiar, nutritionally appropriate food to patients in the hospital, and recently opened an expanded center in Roseville where patients and their siblings can engage in healing through art and play therapy.

  • FACT accreditation for adult, pediatric stem cell transplant programs

    The Stem Cell Transplant Program and Pediatric Bone Marrow Transplant Program at UC Davis Health have received reaccreditation from the Foundation for the Accreditation of Cellular Therapy (FACT). The dual reaccreditation affirms that UC Davis Health continuously meets or exceeds international standards for stem cell collections, processing and complete care during the patient’s entire transplant journey. This is the first year the Pediatric Bone Marrow Transplant Program has received FACT accreditation since the program was revitalized by pediatric hematologist and oncologist Lisa Madden, M.D., in 2023.

  • The region’s only NCI-designated center

    UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Our team includes experts such as chief of pediatric hematology and oncology Marcio Malogolowkin, M.D., an international leader in pediatric liver tumors and an authority on adolescent and young adult (AYA) cancers.